Generex Biotechnology Corporation and SciGen Ltd Enter Into Distribution Agreement for Generex Oral-lyn in China

WORCESTER, Mass., April 1, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, and SciGen, Ltd. (ASX:SIE) (www.scigenltd.com) announced today that the parties have entered into a product licensing and distribution agreement under which SciGen will procure governmental approvals for the importation, marketing, distribution, and sale of Generex Oral-lyn(tm), the Company's proprietary oral insulin spray product, in the People's Republic of China, Hong Kong, and the following additional countries: Indonesia, South Korea, Malaysia, the Philippines, Singapore, Thailand, and Vietnam.